Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial
Catherine Hanna(Princeton University), J. T. Scott(MRC University of Glasgow Centre for Virus Research), Saye Khoo(University of Liverpool), Andrea Taladriz‐Sender(University of Strathclyde), Kevin G. Blyth(Queen Elizabeth University Hospital), Raman Sharma(Liverpool School of Tropical Medicine), Ibrahim Khadra(University of Strathclyde), Glenn A. Burley(University of Strathclyde), Samantha Carmichael(NHS Greater Glasgow and Clyde), Liz-Anne Lewsley(University of Glasgow), Samantha Hinsley(University of Leeds), Emma C. Thomson(MRC University of Glasgow Centre for Virus Research), R. R. Jones(NHS Greater Glasgow and Clyde), Carol Evans(University of Glasgow)
Cited by 9
Related Papers
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
|Cell|2021|656
MAIT cells are activated during human viral infections
|Nature Communications|2016|526
SARS-CoV-2 within-host diversity and transmission
|Science|2021|437
Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol
|The Lancet Regional Health - Europe|2021|322
Directed DNA Metallization
|Journal of the American Chemical Society|2006|284